Severe skin reaction due to excipients of an oral iron treatment.
Rogkakou
A
A
Allergy & Respiratory Diseases, Department of Internal Medicine, Padiglione Maragliano, Genoa, Italy.
Guerra
L
L
Scordamaglia
A
A
Canonica
G W
GW
Passalacqua
G
G
D000284:Administration, Oral; D000328:Adult; D018798:Anemia, Iron-Deficiency / Q000188:drug therapy; D001391:Azo Compounds / Q000008:administration & dosage / Q000009:adverse effects* / Q000378:metabolism; D004396:Coloring Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000378:metabolism; D003875:Drug Eruptions / Q000209:etiology*; D005079:Excipients / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D005296:Ferrous Compounds / Q000008:administration & dosage; D006397:Hematinics / Q000008:administration & dosage; D006801:Humans; D013607:Tablets / Q000008:administration & dosage / Q000737:chemistry
D001391:Azo Compounds; D004396:Coloring Agents; D005079:Excipients; D005296:Ferrous Compounds; D006397:Hematinics; D013607:Tablets; C020748:ferrous sulfate; C005842:6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt